Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
4.350
-0.040 (-0.91%)
Apr 29, 2025, 11:19 AM EDT - Market open
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $241.91 million as of April 29, 2025. Its market cap has decreased by -21.72% in one year.
Market Cap
241.91M
Enterprise Value
37.52M
1-Year Change
-21.72%
Ranking
Category
Stock Price
$4.35
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $241.91M, a decrease of -57.22%. That is a compound annual growth rate of -17.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 242.47M | -7.60% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | 721.42M | 27.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 791.81B |
| UnitedHealth Group | 379.71B |
| Johnson & Johnson | 374.51B |
| AbbVie | 340.70B |
| Novo Nordisk | 280.41B |
| Abbott Laboratories | 225.81B |
| AstraZeneca | 218.53B |
| Novartis AG | 214.73B |